Thus, in this study, we tested the hypothesis that down regulation of miR-21 and EZH2 expression level via anti-miR-21 or EZH2 shRNA reduce LCSC growth, thereby altering lung cancer development and progression. This evidence concerns the gene EZH2 and lung carcinoma.